Integrated Antibody Platforms & Specialty Reagents

As a trusted partner in biopharma R&D, ACROBiosystems (ACRO) is driven by real-world application needs and focused on addressing critical challenges across biologics development, quality control, and clinical translation. At the core of our capabilities is an integrated, end-to-end antibody development platform designed to support the full development lifecycle.

Leveraging deep scientific expertise and scalable in-house R&D capabilities, ACRO seamlessly integrates immunogen preparation, antibody discovery, high-throughput recombinant expression, precision screening, automated purification, and application-specific validation. Building on this technology platform, we have developed a differentiated portfolio of specialty antibody reagents covering a broad range of biopharma R&D applications. By combining robust technology capabilities with high-value products, ACRO supports customers from early-stage research through clinical translation, helping accelerate the development of high-quality biologics and advance biomedicine innovation.